Approved for adults with advanced renal cell carcinoma (kidney cancer / RCC) and for adults with advanced soft tissue sarcoma (STS) who have received prior chemotherapy — excluding adipocytic STS and gastrointestinal stromal tumors (GIST), which are not covered by this indication.